Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells

Cellular Immunology

Volumn 223, Issue 1, 2003, Pages 63-69

  Xiao, Bao Guo ^a,b   Duan, Rui Sheng ^a   Link, Hans ^a   Huang, Yu Min ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FUDAN UNIVERSITY   (China)

Author keywords

Anti acetylcholine receptor antibody; B cell activating factor; Dendritic cells; Experimental autoimmune myasthenia gravis; Tolerance

Indexed keywords

B CELL ACTIVATING FACTOR; CHOLINERGIC RECEPTOR; FREUND ADJUVANT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; PROTEIN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BONE MARROW CELL; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE RESISTANCE; FEMALE; IMMUNIZATION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; MYASTHENIA GRAVIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL;

EID: 0042665907     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00118-7     Document Type: Article

References (41)

1. Dubois B., Barthelemy C., Durand I., Liu Y.J., Caux C., Briere F. Toward a role of dendritic cells in the germinal center reaction: triggering of B cell proliferation and isotype switching. J. Immunol. 162:1999;3428-3436.
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:2000;767-811.
3. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271-296.
4. Jenkinson E.J., Jhittay P., Kingston R., Owen J.J. Studies of the role of the thymic environment in the induction of tolerance to MHC antigens. Transplantation. 39:1985;331-333.
5. Thomson A.W., Lu L. Are dendritic cells the key to liver transplant tolerance. Immunol. Today. 20:1999;27-32.
6. Yarilin D., Duan R.S., Huang Y.M., Xiao B.G. Dendritic cells exposed in vitro to TGF-β1 ameliorate experimental autoimmune myasthenia gravis. Clin. Exp. Immunol. 127:2002;214-219.
7. Link H., Xiao B.G. Rat models as tool to develop new immunotherapies. Immunol. Rev. 184:2001;117-128.
8. Viney J.L., Mowat A.M., O'Malley J.M., Williamson E., Fanger N.A. Expanding dendritic cells in vivo enhances the induction of oral tolerance. J. Immunol. 160:1998;5815-5825.
9. Steinbrink K., Wolfl M., Jonuleit H., Knop J., Enk A.H. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:1997;4772-4780.
10. Steinbrink K., Jonuleit H., Muller G., Schuler G., Knop J., Enk A.H. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood. 93:1999;1634-1642.
11. Feili-Hariri M., Dong X., Alber S.M., Watkins S.C., Salter R.D., Morel P.A. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes. 48:1999;2300-2308.
12. Khoury S.J., Gallon L., Chen W., Betres K., Russell M.E., Hancock W.W., Carpenter C.B., Sayegh M.H., Weiner H.L. Mechanisms of acquired thymic tolerance in experimental autoimmune encephalomyelitis: thymic dendritic-enriched cells induce specific peripheral T cell unresponsiveness in vivo. J. Exp. Med. 182:1995;357-366.
13. Huang Y.M., Yang J.S., Xu L.Y., Link H., Xiao B.G. Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin. Exp. Immunol. 122:2000;437-444.
14. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:2001;233-238.
15. Roncarolo M.G., Levings M.K., Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 193:2001;F5-F9.
16. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245-252.
17. Batten M., Groom J., Cachero T.G., Qian F., Schneider P., Tschopp J., Browning J.L., Mackay F. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192:2000;1453-1466.
18. Lindstrom J., Einarson B., Tzartos S. Production and assay of antibodies to acetylcholine receptors. Methods Enzymol. 74:1981;432-460.
19. Shi F.D., Wang H.B., Li H.L., Hong S., Taniguchi M., Link H., Kaer L.V., Ljunggren H.G. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1:2000;245-251.
20. Link H., Olsson O., Sun J.B., Wang W.Z., Andersson G., Ekre H.P., Brenner T., Abramsky O., Olsson T. Acetylcholine receptor reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87:1991;2191-2196.
21. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Immunol. Rev. 2:2002;465-475.
22. Morelli A.E., Hackstein H., Thomson A.W. Potential of tolerogenic dendritic cells for transplantation. Semin. Immunol. 13:2001;323-335.
23. Xiao B.G., Huang Y.M., Yang J.S., Xu L.Y., Link H. Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats. Clin. Exp. Immunol. 125:2001;300-309.
24. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., Rixon M., Schou O., Foley K.P., Haugen H., McMillen S., Waggie K., Schreckhise R.W., Shoemaker K., Vu T., Moore M., Grossman A., Clegg C.H. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease, impaired B cell maturation in mice lacking BLyS. Immunity. 2:2001;289-302.
25. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., Tschopp J., Browning J.L. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190:1999;1697-1710.
26. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., Hawkins N., Kelley M., Chang D., Van G., Ross L., Delaney J., Wang L., Lacey D., Boyle W.J., Hsu H. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA. 97:2000;3370-3375.
27. Xia X.Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M., Theill L.E., Colombero A., Solovyev I., Lee F., McCabe S., Elliott R., Miner K., Hawkins N., Guo J., Stolina M., Yu G., Wang J., Delaney J., Meng S.Y., Boyle W.J., Hsu H. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J. Exp. Med. 192:2000;137-143.
28. Groom J., Kalled S.L., Cutler A.H., Olson C., Woodcock S.A., Schneider P., Tschopp J., Cachero T.G., Batten M., Wheway J., Mauri D., Cavill D., Gordon T.P., Mackay C.R., Mackay F. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109:2002;17-18.
29. Zhang J., Roschke V., Baker K.P., Wang Z., Alarcon G.S., Fessler B.J., Bastian H., Kimberly R.P., Zhou T. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166:2001;6-10.
30. Cheema G.S., Roschke V., Hilbert D.M., Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44:2001;1313-1319.
31. Mackay F., Mackay C.R. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 23:2002;113-115.
32. Parry T.J., Riccobene T.A., Strawn S.J., Williams R., Daoud R., Carrell J., Sosnovtseva S., Miceli R.C., Poortman C.M., Sekut L., Li Y., Fikes J., Sung C. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice. J. Pharmacol. Exp. Ther. 296:2001;396-404.
33. Lambolez F., Jooss K., Vasseur F., Sarukhan A. Tolerance induction to self antigens by peripheral dendritic cells. Eur. J. Immunol. 32:2002;2588-2597.
34. Nardelli B., Belvedere O., Roschke V., Moore P.A., Olsen H.S., Migone T.S., Sosnovtseva S., Carrell J.A., Feng P., Giri J.G., Hilbert D.M. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood. 97:2001;198-204.
35. Hodgkin P.D., Basten A. B cell activation, tolerance and antigen-presenting function. Curr. Opin. Immunol. 7:1995;121-129.
36. Dubois B., Vanbervliet B., Fayette J., Massacrier C., Van Kooten C., Briere F., Banchereau J., Caux C. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 185:1997;941-951.
37. MacLennan I., Vinuesa C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 17:2002;235-238.
38. Wu B., Deng C., Goluszko E., Christadoss P. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 159:1997;3016-3023.
39. Shi F.D., Bai X.F., Li H.L., Huang Y.M., van der Meide P.H., Link H. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 111:1998;506-512.
40. Yang B., McIntosh K.R., Drachman D.B. How subtle differences in MHC class II affect severity of experimental myasthenia gravis. Clin. Immunol. Immunopathol. 86:1998;45-58.
41. Saoudi A., Kuhn J., Huygen K., de Kozak Y., Velu T., Goldman M., Druet P., Bellon B. Role of the TH1-TH2 balance in the development of autoimmunity in rats. Transplant Proc. 25:1993;2824-2825.